##
##
|C ON|T|EN TS||
|---|---|---|---|
|Management
and Committees||||
|Legal and Administrative
information||||
|Report ofthe Trustees||||
|Pain Relief Foundation
Aims and Policies||||
|Chronic Pain||||
|Research and the Institute||||
|Research Accommodation|||10|
|Management
Structure
& Governance|||12|
|Risk Management
&assessment|||13|
|Trustee Recruitment|||13|
|Advisory Sub-Committees|||14|
|Grant Making
&Policies|||15|
|Public Benefit|||16|
|Powers ofInvestment
& Investment|Policy||17|
|Reserves|||18|
|Fundraising
Regulator
&our fundraising||promise|19|
|Donation Policy|||20to 21|
|Statement of Trustee Responsibilities|||22|
|Clinical Section & Education|||23 to 26|
|Research Reports|||26 to28|
|Auditor's
Report|||29 to 31|
|Statement ofFinancial Activities|||32|
|Balance Sheet|||33 to34|
|Cash Flow Statement|||35to 36|
|Notes forming part ofthe Financial Statements|||37to 44|
|Detailed statement ofFinancial Activities|||45 to 46|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Costs for 50%oft|he Chairin Pain Science,|
University|
ofLiverpool.|
ofLiverpool.||
|---|---|---|---|---|---|
|Dr Maria Maiaru|'Targeting
ion channels|to combat|pathophysiology
of||663,140|
|Reading|chemotherapy-induced|peripheral|neuropathy|(over 3years)||
|Dr Anne Marshall|'REliabilily ofHRDD as|a biomarkerin
Painful||diabeti||
|Liverpool|cnEuropathy
-a validation
study||(REPEL)||525,763|
||(Over 8months)|||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||5.4.23|5.4.22|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|Total|
||||Notes|funds
f|fundf|funds|funds|
|INCOME AND ENDOWMENTS||FROM||||||
|Donations
and legacies|||3|373,501||373,501|184,392|
|Other trading
activities||||42,523||42,523|4,254|
|Investment
income||||95,054||95,054|89,475|
|Total||||511,078||511,078|278,121|
|EXPENDITURE ON||||||||
|Raising funds||||||||
|Other trading
activities|||5|14,837||14,837|14,677|
|Investment
management|costs||7|12017||12,017|12,469|
|||||26,854||26,854|27,146|
|Charitable
activities|||8|||||
|Research||||469,382|300|469,682|413,088|
|Education|||||||5,759|
|Total||||496,236|300|496,536|445,993|
|Net gains/(losses)
on investments||||$151,442)||$151,442)|254,619|
|NET INCOME/(EXPENDITURE)||||(136,600)|(300)|(136,900)|86,747|
|RECONCILIATION
OF|FUNDS|||||||
|Total funds brought
forward||||3,001,458|25,643|3,027,101|2,940,354|
|TOTAL FUNDS CARRIED FORWARD||||2,864,858|25,343|2,890,201|3,027,101|
##
||||||5.4.23|5.4.22|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
|||Notes|funds
f|fund
5|funds|fundsf|
|FIXEDASSETS|||||||
|Tangible assets||14|61,366|901|62,267|73,117|
|Investments||15|2,695,242||2,695,242|2,949,283|
||||2,756,608|901|2,757,509|3,022,400|
|CURRENT ASSETS|||||||
|Stocks||16|662||662|700|
|Debtors||17|(3,724)||(3,724)|9,558|
|Cash at bank and|in hand||179,314|24,442|203,756|45,291|
||||176,252|24,442|200,694|55,549|
|CREDITORS|||||||
|Amounts
falling due within one year||18|(68,002)||(68,002)|(50,848)|
|NET CURRENT ASSETS|||108,250|24,442|132,692|4,701|
|TOTAL ASSETS|LESSCURRENT||2,864,858|25,343|2,890,201|3,027,101|
|LIABILITIES|||||||
|NET ASSETS|||2,864,858|25,343|2,890,201|3,027,101|
|FUNDS||20|||||
|Unrestricted
funds:|||||||
|General
fund|||||141,987|31,380|
|Designated
unrestricted|||||2,722,871|2,970,078|
||||||2,864,858|3,001,458|
|Restricted funds:|||||||
|Restricted
fund|||||25,343|25,543|
|TOTAL FUNDS|||||2,890,201|3,027,101|
##
|||||Notes|5.4.23|5.4.22
f|
|---|---|---|---|---|---|---|
|Cash flows from operating||activities|||||
|Cash generated
from operations||||1|(39,408)|(243,957)|
|Finance costs paid|||||(340)|(261)|
|Tax paid|||||12,051|~6,163|
|Net cash used
in operating|activities||||(27,595)|(250,381)|
|Cash flows from investing||activities|||||
|Purchase offixed asset investments|||||(71,543)|(222,186)|
|Sale oftangible
fixed assets||||||1,186|
|Sale of5xed asset investments|||||174,142|332,787|
|Interest received|||||2||
|Dividends
received|||||95,052|89,473|
|Net cash provided
by investing|||activities||197,553|201,260|
|Change
in cash and cash|||||||
|equivalents
in the reporting||period|||189,958|(49,121)|
|Cash and cash equivalents||at|the||||
|beginning
ofthe reporting||period||2|33,798|82,919|
|Cash and cash equivalents||at|the||||
|end ofthe reporting
period|||||203,755|33,798|
##
##
||||||||5.4.23|5.4.22|
|---|---|---|---|---|---|---|---|---|
||Net (expenditure)/income|||for the reporting|period (as per||||
||the Statement ofFinancial|||Activities)|||(136,900)|86,747|
||Adjustments
for:||||||||
||Depreciation
charges||||||10,850|13,380|
||Losses/(gain)
on investments||||||151,442|(254,619)|
||Profit on disposal of|fixed assets||||||(1,186)|
||Interest received||||||(2)||
||Finance costs||||||340|261|
||Dividends
received||||||(95,052)|(89,473)|
||Decrease
in stocks||||||38|76|
||Decrease
in debtors||||||1,231|8,038|
||Increase/(decrease)||in creditors||||28,647|~7,181|
||Net cash used
in operations||||||~39,406)|(243,957)|
|2,|ANALYSIS OF CASH AND|||CASH EQUIVALENTS|||||
||||||||5.4.23|5.4.22|
||||||||6|f|
||Cash in hand||||||4|4|
||Notice deposits (less||than 3|months)|||203,752|45,287|
||Overdrafts
included|in bank||loans and overdrafts||falling due within||(11,493)|
||one year||||||||
||Total cash and cash||equivalents||||203,756|33,798|
##
|ANALYSIS OF C|HANGES
IN NET FUN|DS|||
|---|---|---|---|---|
|||At 6.4.22|Cash flow|At 5.4.23|
|||f|6||
|Net cash|||||
|Cash at bank and|in hand|45,291|158,465|203,756|
|Bank overdraft||{11,493)|11,493||
|||33,798|169,958|203,756|
|Total||33,798|169,958|203,756|
##
##
##
|costs ofthe chair ofProfess|or|of Pai|n.||||||
|---|---|---|---|---|---|---|---|---|
||||||||2023|2022|
|investment
income:|||||||||
|Interest received|||||||1,709|2,908|
|Dividends|||||||93,342|86,564|
|Realised gains on investments||sold|||||(3,267)|100,175|
|Unrealised
gain on revaluing||investments|||to market value||||
|Total designated
income|||||||91,784|189,647|
|Less:|||||||||
|Realised loss on sale ofinvestments|||||||||
|Unrealised
profit/(loss)
on revaluing|||investments|||to market value|(148,175)|154,444|
||||||||(12,017)|(12,469)|
|Expenditure
out ofdesignated
Transfer ofnet expenditure
to||funds
General||Fund|||~178SOD|~227 DDO|
|Net designated
(expenditure)/income|||||||(247,207)|104,622|
|ACCOUNTING
POLICIES|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|3.|DONATIONS
AND LEGACIES||||
|---|---|---|---|---|
||||5.4.23
f|5.4.22
f|
||Gifts||68,197|89,086|
||Gift aided donations||5,846|29,047|
||Tax recovered
on gift aided donations||(4,789)|7,262|
||Legacies||303,436|58,530|
||Sundry income||811|467|
||||373,501|184,392|
|4.|OTHER TRADING ACTIVITIES||||
||||5.4.23
F|5.4.22
f|
||Fundraising
events||950||
||Books leaflets tapes||133|145|
||Sponsorships||6,217|100|
||EFICCancer School||31,173||
||Meeting fees||4,050|4,009|
||||42,523|4,254|
|5.|INVESTMENT INCOME||||
||||5.4.23|5.4.22
f|
||Rents received|||2|
||Listed investments||95,052|89,473|
||Deposit account interest||2||
||||95,054|89,475|
|6.|OTHER TRADING ACTIVITIES||||
||||5.4.23
f|5.4.22
f|
||Purchases||63|76|
||Staff costs||14,774|14,601|
||||14,837|14,677|
|7,|INVESTMENT MANAGEMENT|COSTS|||
||||5.4.23
f|5.4.22
f|
||Portfolio management||12,017|12,469|
##
##
|CHARITA|BLE ACTIVITIES CO|STS|||||
|---|---|---|---|---|---|---|
||||Grant||||
||||funding|of|||
||||activities||Support||
|||Direct|(see note||costs (see||
|||Costs|9)||note 10)|Totals|
|||F|||6|8|
|Research||106,646|291,932||71,104|469,682|
|GRANTS|PAYABLE||||||
||||||5.4.23|5.4.22|
||||||6|f|
|Research|||||291,932|282,658|
|10.|SUPPORT|COSTS|||||||
|---|---|---|---|---|---|---|---|---|
|||||||Information|Governance||
||||Management|||Finance|technology|costs|
|||||Totals|||||
||||||F||6||
||Research||39,671||329|5,251|25,853|71,104|
##
||||5.4.23|5.4.22
f|
|---|---|---|---|---|
|Auditors'|remuneration||5,000|5,000|
|Auditors'|remuneration|for non audit work|3,340|3,340|
|Depreciation
- owned assets|||10,850|13,379|
|Other operating
leases|||6,426|3,975|
|Surplus|on disposal of|fixed assets||~1,186)|
##
##
##
##
|TANGIBLE FIXEDASSETS|||||
|---|---|---|---|---|
||||Fixtures||
||Long|Plant and|and||
||leasehold
F|machinery
f|fittings|Totals
F|
|COST|||||
|At 8 April 2022 and 5 April 2023|114,302|204,403|324,487|643,192|
|DEPRECIATION|||||
|At 6 April 2022|71,521|176,435|322,119|570,075|
|Charge for year|3,266|6,992|592|10,850|
|At 5 April 2023|74,787|183,427|322,711|580,925|
|NET BOOK VALUE|||||
|At 5 April 2023|39,515|20,976|1,776|62,267|
|At 5 April 2022|42,781|27,968|2,368|73,117|
##
##
|FIXEDA|SSET INVESTMENTS||
|---|---|---|
|||Listed|
|||investments|
|||F|
|MARKET|VALUE||
|At 6 April|2022|2,949,283|
|Additions|at cost|71,543|
|Disposals at book cost
Revaluations||(177,409)
$148,175)|
|At 5 April|2023|2,695,242|
|NET BOOK VALUE|||
|At 5April|2023|2,695,242|
|At 5 April|2022|2,949,283|
|Valuation|in|2023|
|---|---|---|
|Cost|||
##
|16.|STOCKS||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||5.4.23
f|5.4.22
f||
||Finished goods|||||||662|700||
|17.|DEBTORS:AMOUNTS FALLING DUE WITHIN ONE|||||YEAR|||||
|||||||||5.4.23
f|5.4.22
f||
||Tax|||||||(4,789)|7,262||
||Prepayments||and accrued||income|||1,065|2,296||
|||||||||(3,724)|9,558||
|18.|CREDITORS:||AMOUNTS||FALLING DUE WITHIN ONE YEAR||||||
|||||||||5.4.23|5.4.22||
|||||||||f|||
||Bank loans|and overdrafts|||(see note 19)||||11,493||
||Social security||and other taxes||||||123||
||Accruals and deferred|||income||||68,002|39,232||
|||||||||68,002|50,848||
|19.|LOANS||||||||||
||An analysis|of|the maturity||ofloans is given below:||||||
|||||||||5.4.23|5.4.22||
|||||||||f|||
||Amounts
falling due within||||one year on demand:||||||
||Bank overdrafts||||||||11,493||
|20.|MOVEMENT|IN FUNDS|||||||||
||||||||Net|Transfers|||
|||||||movement||between|At||
||||||At 6.4.22|in|funds|funds|5.4.23||
||||||f.|||f|f||
||Unrestricted|funds|||||||||
||General fund
Designated
unrestricted||||31,380
2,970,078|(68,193)
~6$,4D7)||178,800
$178,800)|141,987
2,722,871||
||||||3,001,458|(136,600)|||2,864,858||
||Restricted funds||||||||||
||Restricted
fund||||25,643||(300)||25,343||
||TOTAL FUNDS||||3,027,101|J136,9DD)|||2,890,201||
||||||||||Continued|..|
##
|Net movem|ent
in funds, included|in the above are as fo|llows:|||
|---|---|---|---|---|---|
|||Incoming|Resources|Gains and|Movement|
|||resources
f|expended
f|losses
f|in funds
f.|
|Unrestricted
funds||||||
|General fund||416,026|(484,219)||(68,193)|
|Designated|unrestricted|~95 052|(12,017)|(151,442)|(68,407)|
|||511,078|(496,236)|(151,442)|(136,600)|
|Restricted|funds|||||
|Restricted|fund||(300)||(300)|
|TOTAL FUNDS||511,078|(496,536)|(151,442)|(136,900)|
##
||||Net|Transfers||
|---|---|---|---|---|---|
||||movement|between|At|
|||At 6.4.21
f|in funds
f|funds
f|5.4.22
f|
|Unrestricted
funds||||||
|General
fund||73,854|(269,474)|227,000|31,380|
|Designated|unrestricted|2,865,456|331622|~227,000)|2,970,078|
|||2,939,310|62,148||3,001,458|
|Restricted|funds|||||
|Restricted|fund|1,044|24,599||25,643|
|TOTAL FUNDS||2,940,354|86,747||3,027,101|
|Comparativ|e
net movement
in fu|nds,
included
in the ab|ove are as foll|ows:||
|---|---|---|---|---|---|
|||Incoming|Resources|Gains and|Movement|
|||resources
f|expended
f|losses
f|in funds
f|
|Unrestricted
funds||||||
|General fund||163,649|(433,123)||(269,474)|
|Designated|unrestricted|89,472|~12,469)|254,619|331,622|
|||253,121|(445,592)|254,619|62,148|
|Restricted|funds|||||
|Restricted|fund|25,000|(401)||24,599|
|TOTAL FUNDS||278,121|(445,993)|254,619|86,747|
##
||||Net|Transfers||
|---|---|---|---|---|---|
||||movement|between|At|
|||At6.4.21|in funds
f|funds
f|5.4.23
f|
|Unrestricted
funds||||||
|General fund||73,854|(337,667)|405,800|141,987|
|Designated|unrestricted|2,865,456|263,215|~405,800)|2,722,871|
|||2,939,310|(74,452)||2,864,858|
|Restricted|funds|||||
|Restricted|fund|1,044|24,299||25,343|
|TOTAL FUNDS||2,940,354|~50,153)||2,890,201|
|A current
the above|year 12 months
and pri
are as follows:|or year 12 months
com|bined
net mov|ement
in fund|s,
included|
|---|---|---|---|---|---|
|||Incoming|Resources|Gains and|Movement|
|||resources
6|expended|losses
f|in funds
6|
|Unrestricted
funds||||||
|General
fund||579,675|(917,342)||(337,667)|
|Designated|unrestricted|184,524|(24,486)|103,177|263,215|
|||764,199|(941,828)|103,177|(74,452)|
|Restricted|funds|||||
|Restricted|fund|25,000|(701)||24,299|
|TOTAL FUNDS||789,199|(942,529)|103,177|(50,153)|
##
##
##
|||||5.4.23|5.4.22|
|---|---|---|---|---|---|
|||||5|6|
|INCOME AND|ENDOWMENTS|||||
|Donations
and|legacies|||||
|Gifts||||68,197|89,088|
|Gift aided donations||||5,846|29,047|
|Tax recovered|on gift aided donations|||(4,789)|7,252|
|Legacies||||303,436|58,530|
|Sundry
income||||811|467|
|||||373,501|184,392|
|Other trading activities||||||
|Fundraising
events||||950||
|Books leaflets tapes||||133|145|
|Sponsorships||||6,217|100|
|EFIC Cancer School||||31,173||
|Meeting fees||||4,050|4,009|
|||||42,523|4,254|
|Investment
income||||||
|Rents received|||||2|
|Listed investments||||95,052|89,473|
|Deposit account interest||||2||
|||||95,054|89,475|
|Total incoming|resources|||511,078|278,121|
|EXPENDITURE||||||
|Other trading activities||||||
|Purchases||||63|76|
|Wages||||14,300|14,100|
|Social security||||306|343|
|Pensions||||168|158|
|||||14,837|14,677|
|Investment
management|||costs|||
|Portfolio management||||12,017|12,469|
|Charitable
activities||||||
|Wages||||54,393|50,675|
|Social security||||1,057|1,543|
|Pensions||||1,684|1,584|
|Venue &meeting costs||||37,473|2,468|
|Sundry||||1,189|278|
|Depreciation
of|tangible|fixed assets||10,850|13,380|
|Loss on sale of|tangible|fixed assets|||(1,186)|
|Grants to individuals||||291,932|282,558|
|||||398,578|351,400|
##
||||5.4.23f|5.4.22f|
|---|---|---|---|---|
|Supportcosts|||||
|Management|||||
|Other operating
leases|||6,426|3,975|
|Rates and water|||17,505|17,548|
|Insurance|||2,974|2,571|
|Telephone|||1,117|1,047|
|Postage and stationery|||2,936|1,791|
|Advertising|||5,252|7,611|
|Sundries|||1,002|235|
|Travel|||852|501|
|Computer
software|||1,267|1,352|
|Credit card charges|||340|261|
||||39,671|36,892|
|Finance|||||
|Bank charges|||329|150|
|Information
technology|||||
|Repairs and renewals|||5,251|5,056|
|Governance costs|||||
|Wages|||16,600|15,800|
|Social security|||239|370|
|Pensions|||674|634|
|Auditors'
remuneration|||5,000|5,000|
|Auditors'
remuneration|for|non audit work|3,340|3,340|
|Postage and stationery||||205|
||||25,853|25,349|
|Total resources expended|||496,536|445,993|
|Net income/(expenditure)||before gains|||
|and losses|||14,542|(167,872)|
|Realised recognised
Net investment
gains/|gains and losses
(losses)||J3,267)|100,175|
|Net income/(expenditure)|||11,275|~67,697)|
Pain Relief Foundation